NCT04500028View on ClinicalTrials.gov

Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System

PHASE4CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

December 1, 2021

Conditions

IUCD Complication

Interventions

DRUG

INH

3 vaginal tablet of isonicotinic acid hydrazide (900mg) inserted by the study nurse 4 hours before IUD insertion.

DRUG

Placebo Comparator

3 tablet of placebo inserted by the study nurse 4 hours before IUD insertion.

Trial Locations (1)

81528

Aswan University Hospital, Aswān

All Listed Sponsors

lead

Aswan University Hospital

OTHER

NCT04500028 - Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System | Biotech Hunter | Biotech Hunter